Cutaneous Leishmaniasis Completed Phase 2 Trials for Pentamidine (DB00738)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03445897Miltefosine Plus IL Pentamidine for Bolivian CLTreatment